Ben Tre Pharmaceutical JSC (HOSE:DBT)
Vietnam · Delayed Price · Currency is VND 10,900
0.00 (0.00%)
At close: Apr 10, 2026
HOSE:DBT Revenue
In the year 2025, Ben Tre Pharmaceutical JSC had annual revenue of 860.31B VND, down -0.93%. Ben Tre Pharmaceutical JSC had revenue of 278.91B in the quarter ending December 31, 2025, with 7.94% growth.
Revenue
860.31B
Revenue Growth
-0.93%
P/S Ratio
0.28
Revenue / Employee
1.26B
Employees
684
Market Cap
239.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 860.31B | -8.10B | -0.93% |
| Jan 1, 2025 | 868.41B | 56.80B | 7.00% |
| Dec 31, 2023 | 811.62B | 11.12B | 1.39% |
| Dec 31, 2019 | 800.50B | -9.41B | -1.16% |
| Dec 31, 2018 | 809.91B | 9.80B | 1.22% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vimedimex Medi-Pharma JSC | 1.17T |
| OPC Pharmaceutical JSC | 1.12T |
| Vidipha Central Pharmaceutical JSC | 985.64B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.57B |
| Central Pharmaceutical Joint Stock Company No3 | 438.01B |
| Mediplantex National Pharmaceutical JSC | 366.83B |
| SPM Corporation | 253.96B |
| Lamdong Pharmaceutical JSC | 243.91B |